Botulinum toxin type A may help reduce inflammation in hidradenitis suppurativa (HS) by inhibiting mast cell degranulation.

Some individuals sweat excessively compared to others, to the extent that their clothes become drenched. This excessive ...

The Japan axillary hyperhidrosis treatment market is experiencing significant growth, with projections indicating a rise from USD 66.9 million in 2025 to USD 134.1 million by 2035, reflecting a CAGR ...

The India axillary hyperhidrosis treatment market is on a strong growth trajectory, projected to expand at a CAGR of 10.1%, rising from USD 75.2 million in 2025 to USD 196.8 million by 2035. This ...

Primary axillary hyperhidrosis is a condition characterized by excessive underarm sweating and has long presented challenges ...

Dermata Therapeutics (DRMA) announced the Australian Patent Office has accepted its patent application for its DMT410 program for the treatment ...

Dermata Therapeutics (DRMA) announced the Australian Patent Office has accepted its patent application for its DMT410 program for the treatment ...

This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial ...

This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum ...

Thyroid disorders are common and affect millions. Proper management includes understanding causes, early detection, and ...

Some people sweat excessively as compared to others. This condition, called hyperhidrosis, causes discomfort as the body produces more sweat than required, even without heat or exertion.

Niamh said: “Halitosis, or chronic bad breath, affects many people but is often left unspoken due to embarrassment. Typically ...